Ascentage Pharma’s Phase III study of Olverembatinib cleared by FDA
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
The new campus has been designed as an employee-centred experience and ecosystem zone
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Leading USA based genetic testing brand officially enters the Indian market
Subscribe To Our Newsletter & Stay Updated